Prescription Required
Consuming alcohol with Fastclav 125 mg/31.25 mg Dry Syrup does not cause any harmful side effects.
Fastclav 125 mg/31.25 mg Dry Syrup is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby however, there are limited human studies.
Fastclav 125 mg/31.25 mg Dry Syrup is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Not relevant, as Fastclav 125 mg/31.25 mg Dry Syrup is intended for use in hospitalised patients.
There is limited information available on the use of Fastclav 125 mg/31.25 mg Dry Syrup in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Fastclav 125 mg/31.25 mg Dry Syrup in patients with liver disease. Please consult your doctor.
Fastclav 125 mg/31.25 mg Dry Syrup is a combination of two medicines: Cefuroxime and Clavulanic Acid. Cefuroxime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Clavulanic Acid is a beta-lactamase inhibitor which blocks the action of enzymes produced by bacteria to inactivate Cefuroxime. Addition of Clavulanic Acid reduces resistance and enhances the activity of Cefuroxime against bacteria.
Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA